Randomized, placebo controlled trial of withdrawal of slow-acting antirheumatic drugs and of observer bias in rheumatoid arthritis
- PMID: 8792795
- DOI: 10.3109/03009749609069987
Randomized, placebo controlled trial of withdrawal of slow-acting antirheumatic drugs and of observer bias in rheumatoid arthritis
Abstract
Patients with rheumatoid arthritis, in stable treatment with methotrexate, penicillamine, or sulfasalazine, were randomized in a double-blind fashion either to continuation of their usual treatment or to placebo. 112 patients were included; 52 patients who refused participation had no more severe disease than the others. The patients felt worse on placebo than on active drug (p = 0.002). The mean differences in number of tender, painful and swollen joints after one month were 2.4 (p = 0.08), 3.0 (p = 0.12) and 2.2 (p = 0.03), respectively. Treatment failure occurred for 42 patients of whom 33 received placebo (p = 0.000,001). There was no difference in the severity of side effects (p = 0.91). The patients guessed their treatment correctly more often than expected (p = 0.02) because of the perceived effect. None of the two observers guessed better than chance, and there were no differences between the observers' evaluations of the joints. The effect of slow-acting antirheumatic drugs was unequivocal and no observer bias occurred.
Similar articles
-
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.Lancet. 2009 Jul 18;374(9685):210-21. doi: 10.1016/S0140-6736(09)60506-7. Epub 2009 Jun 26. Lancet. 2009. PMID: 19560810 Clinical Trial.
-
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.Lancet. 2013 Mar 16;381(9870):918-29. doi: 10.1016/S0140-6736(12)61811-X. Epub 2013 Jan 17. Lancet. 2013. PMID: 23332236 Clinical Trial.
-
Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.Lancet. 2017 Mar 25;389(10075):1206-1217. doi: 10.1016/S0140-6736(17)30401-4. Epub 2017 Feb 16. Lancet. 2017. PMID: 28215362 Clinical Trial.
-
Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.Prescrire Int. 2010 Feb;19(105):30-4. Prescrire Int. 2010. PMID: 20455343 Review.
-
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.Cochrane Database Syst Rev. 2000;(2):CD000951. doi: 10.1002/14651858.CD000951. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2013 May 31;(5):CD000951. doi: 10.1002/14651858.CD000951.pub2. PMID: 10796393 Updated. Review.
Cited by
-
Defining the Optimal Strategies for Achieving Drug-Free Remission in Rheumatoid Arthritis: A Narrative Review.Healthcare (Basel). 2021 Dec 13;9(12):1726. doi: 10.3390/healthcare9121726. Healthcare (Basel). 2021. PMID: 34946453 Free PMC article. Review.
-
Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission?Am J Transl Res. 2017 Aug 15;9(8):3758-3775. eCollection 2017. Am J Transl Res. 2017. PMID: 28861167 Free PMC article.
-
Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis.Open Access Rheumatol. 2017 Mar 31;9:67-79. doi: 10.2147/OARRR.S131668. eCollection 2017. Open Access Rheumatol. 2017. PMID: 28435338 Free PMC article. Review.
-
Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial.PLoS One. 2016 May 18;11(5):e0154842. doi: 10.1371/journal.pone.0154842. eCollection 2016. PLoS One. 2016. PMID: 27191165 Free PMC article. Clinical Trial.
-
Recent advances: rheumatology.BMJ. 2000 Oct 7;321(7265):882-5. doi: 10.1136/bmj.321.7265.882. BMJ. 2000. PMID: 11021871 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical